Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement is to investigate innate immune cell effector functions and innate immune memory as a means to prevent HIV infection and/or establishment of disease. Exploratory research from basic molecular mechanisms, translational work, and clinical research examining innate memory are encouraged.

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date

  • AIDS Deadline: December 06, 2021

RFA-AI-21-041 Expiration Date December 07, 2021

Agency Website

Amount

$275,000

Amount Description

The combined budget for direct costs for the two-year period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

December 6, 2021